The CA 125 test is a blood test primarily used to measure the level of cancer antigen 125 (CA 125) in the blood. Elevated CA 125 levels are commonly associated with ovarian cancer, although high levels can also indicate other types of cancer or benign conditions like endometriosis and fibroids. It is a crucial diagnostic tool used for monitoring ovarian cancer in patients undergoing treatment,...

The gastrointestinal (GI) drugs market in Europe, the Middle East, and Africa (EMEA) has seen notable growth driven by the increasing prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD), peptic ulcers, and gastroesophageal reflux disease (GERD). These conditions are often chronic and require long-term management, which contributes...

CA 125 Test Market Highlights The CA 125 test market share report has calculated at USD 0.8 billion in 2022. It seems likely that the CA 125 Test market business will strengthen from USD 0.9 billion in 2023 to USD 1.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.80% over the forecast time frame (2023-2032). Cancer diagnosis and treatment has extensively evolved in...